Dai started as a Tenure Track Assistant Professor of Medicine at the University of Arizona College of Medicine-Phoenix on 2019, and was promoted as Tenured Associate Professor on July 2024. Dr. Dai was recruited to Washington University in St Louis on July 2024. Dr. Liu has been trained in Cancer Biology at the University of Illinois at Chicago.

Welcome to Zhiyu Dai lab Understanding lung vascular biology and cardiopulmonary diseases We are currently accepting DBBS rotation students ...

Associate Professor of Medicine. My research aims to understand the lung vascular homeostasis and the pathogenesis of pulmonary diseases using novel animal models, integrated pharmacological approaches, genome editing and single …

Prolyl-4 hydroxylase 2 (PHD2) deficiency in endothelial cells and hematopoietic cells induces obliterative vascular remodeling and severe pulmonary arterial hypertension in … Z Dai, MM …

Zhiyu Dai, PhD, FAHA & ATSF Associate Professor of Medicine Director of Endothelial Biology Research Division of Pulmonary, Critical Care Medicine Department of Medicine & Department of Cell Biology and Physiology

We still employ CRISPR/Cas9 genomic editing technology and high throughput screening to identify novel partners of HIF and BMPR2 signaling in the pathogenesis of pulmonary vascular …

Director, Translational Endothelial Research (Department of Internal Medicine), study pulmonary hypertension and lung vascular biology. [...] Background: -Vascular occlusion and complex...

Associate Research Professor, Research Series - Internal Medicine. PhD: Biochemistry and Molecular Biology, Sun Yat-Sen University, Zhongshan School of Medicine, 2013.

Our recent single-cell RNA sequencing, spatial transcriptomics analysis, RNASCOPE, and immunostaining analysis showed that arterial ECs accumulation and loss of capillary ECs were evident in human PAH patients and pulmonary hypertension (PH) rodents.

My research aims to understand the lung vascular homeostasis and the pathogenesis of cardiopulmonary diseases using novel animal models, integrated pharmacological approaches, genome editing and single cell RNA-sequencing and spatial transcriptomics.